People. Deals. Growth.

Astorg and Goldman Sachs Asset Management announce they have received a binding offer and entered into exclusive negotiations with Perrigo for the sale of HRA Pharma.

Demetra to partner with Astorg

Nemera breaks ground in Brazil through Milfra acquisition

ERT and Bioclinica Close Merger, Creating the Global Leader in Clinical Trial Endpoint Technology

Nordic Capital and Astorg invest in pharmaceutical technology and advanced analytics company Cytel

ERT and Bioclinica to Merge, Creating a Global Leader in Clinical Trial Endpoint Technology

Astorg and Cinven to acquire LGC

Nordic Capital, Astorg, and Novo Holdings A/S to invest in ERT for future growth

HRA Pharma Acquires the Mederma® Brand from Merz Pharmaceuticals GmbH